Natriumchlorid-Trägerlösung Medipharm (Sodium Chloride)

Sodium chloride, the active ingredient in Natriumchlorid-Trägerlösung Medipharm, is an electrolyte solution presented as a sterile aqueous solution for injection for intramuscular, intravenous, or subcutaneous use. It provides sodium and chloride ions to restore extracellular fluid volume and electrolyte balance in patients requiring fluid replacement. GNH USA supplies Natriumchlorid-Trägerlösung Medipharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Natriumchlorid-Trägerlösung Medipharm, an electrolyte solution, is employed to manage fluid and electrolyte disorders.

Fluid replacement: restores intravascular volume in patients with dehydration, blood loss, or hypovolemia. Electrolyte balance: supplies sodium and chloride to correct hyponatremia or chloride deficits. Diluent for parenteral medications: serves as a compatible carrier for intravenous drug admixtures.

Common Side Effects: - Pain or irritation at the injection site. - Phlebitis or mild inflammation of the vein. - Mild hypernatremia or hyperchloremia. - Transient edema or localized swelling. - Slight increase in blood pressure.

Serious or Rare Side Effects: - Severe hypernatremia leading to neurological symptoms. - Hyperchloremic metabolic acidosis. - Volume overload causing pulmonary edema. - Anaphylactoid reactions or severe hypersensitivity. - Cardiac arrhythmias due to electrolyte imbalance.

Before administration, consider the following precautions: - Assess fluid status: evaluate volume status and ongoing losses. - Monitor serum electrolytes: check sodium and chloride levels regularly. - Caution in heart failure: avoid rapid large-volume infusion. - Use carefully in renal impairment: adjust volume to prevent overload. - Avoid rapid infusion in neonates and infants. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Potential drug interactions should be reviewed prior to use.

Major Interactions (Avoid): - Hypertonic saline solutions: additive sodium load may cause severe hypernatremia. - Large‑volume blood product transfusions: risk of fluid overload.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase sodium loss, requiring electrolyte monitoring. - ACE inhibitors or ARBs: can affect potassium balance, monitor serum levels. - Corticosteroids: may promote fluid retention, watch for signs of overload.